Ryoichi Bessho, Yumi Takiyama, Takao Takiyama, Hiroya Kitsunai, Yasutaka Takeda, Hidemitsu Sakagami, Tsuguhito Ota. Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy. Scientific reports. 2019. 9. 1. 14754-14754
Takiyama Y, Sera T, Nakamura M, Ishizeki K, Saijo Y, Yanagimachi T, Maeda M, Bessho R, Takiyama T, Kitsunai H, et al. Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8. EBioMedicine. 2018. 36. 329-346
Takao Takiyama, Ryoichi Bessho, Kazuki Sawamoto, Yumi Takiyama. Maternal Overnutrition Causes DNA Alkylation in Fetal Liver, Suppresses FasL, and Upregulates HIF-1 Signaling Pathway in Neonatal Liver in Nonalcoholic Steatohepatitis (NASH)-Based Hepatocellular Carcinoma in Offspring. DIABETES. 2020. 69
Ryoichi Bessho, Yumi Takiyama, Manami Maeda, Kuralay K. Atageldiyeva, Yukihiro Fujita, Masakazu Haneda. Zinc; HIF-1 Mimetic in Human Renal Proximal Tubular Cells. DIABETES. 2016. 65. A137-A137
Yumi Takiyama, Manami Maeda, Kuralay K. Atageldiyeva, Tsuyoshi Yanagimachi, Jun Honjo, Yukihiro Fujita, Atsuko Abiko, Masakazu Haneda. A New Player in Diabetic Nephropathy: Metallothionein 3 Is a Target for Hypoxia Inducible Factor-1. DIABETES. 2015. 64. A142-A142
Y. Takiyama, M. Maeda, K. K. Atageldiyeva, T. Yanagimachi, J. Honjo, Y. Fujita, Y. Makino, M. Haneda. Zinc exerts anti-fibrotic action by inhibiting TGF-beta1-induced type I collagen and fibronectin in human renal proximal tubular cells. DIABETOLOGIA. 2014. 57. S480-S480
Yumi Takiyama, Ryoichi Bessho, Manami Maeda, Kuralay K. Atageldiyeva, Tsuyoshi Yanagimachi, Jun Honjo, Yukihiro Fujita, Yuichi Makino, Masakazu Haneda. SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. DIABETES. 2014. 63. A136-A136